Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch from thymidine nucleoside analogues to lopinavir/ritonavir monotherapy in HIV-associated lipoatrophy
2009-016090-14Phase 4Terminated
- Sponsor
- Dr. Vicente Estrada
- Start
- Oct 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lopinavir and ritonavir in human immunodeficiency virus infection (HIV), sponsored by Dr. Vicente Estrada. Primary endpoints: Change in expression of representative genes of adipose tissue toxicity, Histologic changes in adipose tissue and 1 more. Started Oct 2009; status: terminated.
02
Drugs
lopinavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2009-016090-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016090-14.